Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vitamin C and CoQ10 for Cisplatin-Induced Nephrotoxicity
NCT07476443Phase 3Not yet recruiting
- Sponsor
- Ain Shams University
- Start
- Apr 2026
- Primary completion
- May 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of ascorbic acid, Coenzyme Q10 mucoadhesive tablets in nephrotoxicity, sponsored by Ain Shams University. Planned start Apr 2026; status: not yet recruiting.
02
Drugs
ascorbic acidCoenzyme Q10 mucoadhesive tablets
03
Conditions
nephrotoxicity
Beyond the preview
Go deeper on NCT07476443.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07476443.